Kenshi Suzuki (Department of Hematology, Japanese Red Cross Medical Center)
Session information
Morning Seminar
MS3-9
Immunotherapy of multiple myeloma~Long-term follow-up data Positioning of Elotuzumab~
Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.9 (Osaka International Convention Center, 10F 1008)
Chair: Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)
Sponsor: Bristol-Myers Squibb K.K.